Interchangeable Status Rapidly Boosted Scripts for Insulin Biosimilar

(MedPage Today) -- Prescriptions for insulin glargine-yfgn (Semglee) rapidly increased when its status switched from a standard biosimilar to the first interchangeable insulin biosimilar, an economic evaluation found.
After the biosimilar officially...